4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-005167
Options or other derivatives
- Director acquired 19,936 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Spragens Jeffrey G Director | 2023-02-28 | Other acquisition · Warrants | +19,936 | 19,936 | D | ||
Loading xslF345X03/rdgdoc.xml…